Common Stock, Shares, Issued of Protalix BioTherapeutics, Inc. from 31 Dec 2010 to 31 Dec 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Protalix BioTherapeutics, Inc. quarterly Common Stock, Shares, Issued in shares history and change rate from 31 Dec 2010 to 31 Dec 2024.
  • Protalix BioTherapeutics, Inc. Common Stock, Shares, Issued for the quarter ending 31 Dec 2024 was 75,850,275, a 4% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Change (%)

Protalix BioTherapeutics, Inc. Quarterly Common Stock, Shares, Issued (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 75,850,275 +2,898,151 +4% 31 Dec 2024 10-K 17 Mar 2025 2024 FY
Q4 2023 72,952,124 +19,161,957 +36% 31 Dec 2023 10-K 17 Mar 2025 2024 FY
Q4 2022 53,790,167 +8,233,520 +18% 31 Dec 2022 10-K 14 Mar 2024 2023 FY
Q4 2021 45,556,647 +10,791,367 +31% 31 Dec 2021 10-K 27 Feb 2023 2022 FY
Q4 2020 34,765,280 +19,927,067 +134% 31 Dec 2020 10-K 31 Mar 2022 2021 FY
Q4 2019 14,838,213 0 0% 31 Dec 2019 10-K 30 Mar 2021 2020 FY
Q4 2018 14,838,213 -128,890,584 -90% 31 Dec 2018 10-K 12 Mar 2020 2019 FY
Q4 2017 143,728,797 +19,594,712 +16% 31 Dec 2017 10-K 18 Mar 2019 2018 FY
Q4 2016 124,134,085 +24,333,688 +24% 31 Dec 2016 10-K 06 Mar 2018 2017 FY
Q4 2015 99,800,397 +6,196,578 +6.6% 31 Dec 2015 10-K 16 Mar 2017 2016 FY
Q4 2014 93,603,819 +52,721 +0.06% 31 Dec 2014 10-K 08 Mar 2016 2015 FY
Q4 2013 93,551,098 +61,289 +0.07% 31 Dec 2013 10-K 12 Mar 2015 2014 FY
Q4 2012 93,489,809 +7,859,652 +9.2% 31 Dec 2012 10-K 13 Mar 2014 2013 FY
Q1 2012 5,175,000 +1,175,000 +29% 22 Feb 2012 10-K 13 Mar 2014 2013 FY
Q4 2011 85,630,157 +4,381,685 +5.4% 31 Dec 2011 10-K 28 Feb 2013 2012 FY
Q1 2011 4,000,000 23 Mar 2011 10-K 13 Mar 2014 2013 FY
Q4 2010 81,248,472 31 Dec 2010 10-K 27 Feb 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.